Latest Blogs

Jul 27, 2021
Dr. Nizar Bitar and I review the 2021 Best of ASCO Lebanon meeting, which featured an extraordinary faculty from all over the globe and our talented colleagues here in Lebanon.
Jul 27, 2021
July is a time of new beginnings and transitions in academic medicine. As I wrapped up my fellowship, I thought often of the adage: “Comparison is the thief of joy.”
Jul 22, 2021
Dr. Jennifer Temel and Dr. Daniel E. Lage discuss building a career in cancer symptom management research.
Jul 21, 2021
Dr. Samer Al Hadidi shares how a clear strategy may help to choose the best conference/s to attend according to interest and/or availability. 
Subscribe to this column

Don S. Dizon, MD, FACP, FASCO

Don S. Dizon, MD, FACP, FASCO, is a professor of medicine at Brown University, director of the Breast and Pelvic Malignancies Program and Hematology-Oncology Outpatient Clinics at Lifespan Cancer Institute, and director of Medical Oncology and the Sexual Health First Responders Clinic at Rhode Island Hospital. Dr. Dizon has served as past chair of ASCO's Social Media Working Group and the Cancer Communications Committee. In addition to his regular column on ASCOconnection.org, which has been honored with APEX awards in 2013 and 2014, he is a blogger for The Oncologist and a section editor of Gynecologic Oncology at UpToDate. Dr. Dizon is a member of the JCO Oncology Practice Editorial Board, and editor in chief of the ASCO Educational BookFollow Dr. Dizon across social media channels @drdonsdizon. 

Disclosure.

Mar 31, 2017
When a dying patient wanted more time at any cost, and our team collectively felt that a code would be inhumane, an ethics consultation helped provide clarity and support for our decision-making.
Mar 16, 2017
I tend to be cautious with the word cure, because sometimes that is the only thing that patients hear.
Feb 23, 2017
When the travel ban was announced, I worried for my patients and for my colleagues. I worried that medical care would be denied to international patients, including those who came to the U.S. for cancer care.
Feb 02, 2017
When it comes to many alternative therapies, the data is too sparse to inform discussions on benefits and/or risks, as my patient learned when her supplement use prevented her from continuing on a clinical trial.
Dec 27, 2016
With new therapies, fortunately, oncologists are now seeing patients over the span of years, and we get to know the person who is the patient beyond their illness. Many also bring along others on visit after visit, and we get to know each of them too.
Dec 14, 2016
As we move forward in oncology, my hope is that we will see miraculous recoveries more often, guided not by chance but by a better understanding of cancer biology. The promise of precision medicine remains a real one that I firmly believe in.

Pages